Penumbra today announced the U.S. launch of the Ace68 Reperfusion thrombectomy catheter designed for extracting thrombus in acute ischemic stroke patients. The company said the Ace68 catheter was engineered on an entirely new platform from hub to tip, which features coil winding geometry along 16 transitions to create a more optimal tracking profile. “With the Ace68 Reperfusion Catheter, […]
Blood Management
Cheetah Medical inks supply deal with Allina Health
Cheetah Medical said today it inked a supplier contract with non-for-profit healthcare system Allina Health. Through the contract, Minnesota and western Wisconsin based Allina Health will gain access to Cheetah Medical’s hemodynamic monitoring solutions to help guide volume management decisions in septic patients, Cheetah Medical said. “Intravenous fluid requirements vary significantly between patients based on underlying […]
Magnolia Medical raises $13.8m
Seattle-based Magnolia Medical Technologies said today it raised $13.8 million in a Series B round of financing to support the commercialization of its SteriPath blood collection system. Magnolia produces the SteriPath vacuum-assisted blood collection system designed to divert and sequester contaminants from the initial blood sample specimen, according to the company’s website. The SteriPath unit […]
Leading the battle against sepsis: A MassDevice podcast with Spectral Medical CEO Paul Walker
Spectral Medical CEO Dr. Paul Walker has been focused on finding a solution to identify and treat sepsis, and specifically endotoxins that are known to trigger it, for over 20 years. Sepsis affects approximately 1 million patients in the U.S. each year, and even more worldwide – and treating the deadly condition has proved to […]
Baxter touts remote monitoring study for Amia dialysis device
Baxter (NYSE:BAX) today released the results from a study of its AMIA automated peritoneal dialysis system, touting the value of remote monitoring technology for chronic health conditions for improving access to care, decreasing hospitalization and reducing treatment costs. Results from the study were published in the academic journal Plos One this month, the company said. ”Increasing […]
Spectral Medical wins compassionate use exemption for Toramyxicin
Spectral Medical said today it won compassionate use expanded access from the FDA for its Toraymyxin blood treatment device designed for removing endotoxins from patient’s blood. The Toraymyxin is an investigational therapeutic hemoperfusion device designed to treat patients in septic shock with elevated levels of endotoxins. “As we move to complete our PMA submission for Toraymyxin with […]
Fresenius touts 10-year dialysis mortality reduction
Fresenius (NYSE:FMS) this week released data from an internal annual medical report, touting a 27% reduction in mortality and 22% reduction in hospitalizations amongst its permanent dialysis patients over 10 years. The Waltham, Mass.-based company said the outcomes are a product of the company’s expansion beyond renal service care into care coordination, as well as continued […]
UPDATE: Cerus, Terumo land $48m in BARDA grants for anti-Zika push
Updated with comments from Terumo. Cerus (NSDQ: CERS) and Terumo Corp. (TYO:4543) won grants from a U.S. Health & Human Services Dept. agency worth a collective $48 million to study their respective devices for eliminating blood pathogens like the Zika virus. Zika, which the World Health Organization declared a global emergency in February, has been linked to microcephaly, a birth […]
Spectral Medical touts PMA acceptance for sepsis treatment
Spectral Medical today announced the FDA has reviewed and accepted 1 of 2 pre-clinical modules in its premarket approval application for its Toraymyxin device designed to remove endotoxins from the bloodstream. The Toraymyxin is an investigational therapeutic hemoperfusion device designed to treat patients in septic shock with elevated levels of endotoxins. The Canadian company touted study […]
Exthera Medical closes $15 million Series B for Seraph blood infection filter
Updated to correct funding amounts and include new information from Exthera. By Fink Densford & Varun Saxena Martinez, Calif.-based Exthera Medical said it raised a $15.3 million Series B round following positive tests of its CE-Marked Seraph blood filter in animal studies. The company’s Seraph microbind affinity blood filter is designed to remove a range of sepsis-causing bacteria, […]
Arch Therapeutics raises $3.4m to support novel blood control dev
Arch Therapeutics (OTC:ARTH) said last week it raised $3.4 million through the private placement of the company’s securities with a group of investors. The Framingham, Mass.-based company said it floated approximately 9.5 million shares at 36¢ per share in the placement round. Each unit offered in the round includes 1 share of common stock and […]